The Deal Register
Database › Equity financing › BIOVAXYS ANNOUNCES CLOSING OF UNSECURED CONVERTIBLE DEBENTURE OFFERING

Equity financing

BIOVAXYS ANNOUNCES CLOSING OF UNSECURED CONVERTIBLE DEBENTURE OFFERING

Lane
Equity financing
Announced
16 Sep 2025
Province
British Columbia
Industry
Unclassified
Status
Announced
What the filing says
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (" BioVaxys " or the " Company ") is pleased to announce that it has closed its previously announced non-brokered private placement of unsecured convertible debentures (the " Debentures ") for aggregate gross proceeds of $335,670 (the " Offering ").
Terms stated
exercise price, interest rate, maturity date
Releases (2)
  • 27 Aug 2025 — BIOVAXYS ANNOUNCES UNSECURED CONVERTIBLE DEBENTURE OFFERING AND CANCELLATION OF BROKERED LIFE OFFERING
  • 16 Sep 2025 — BIOVAXYS ANNOUNCES CLOSING OF UNSECURED CONVERTIBLE DEBENTURE OFFERING
Source

The terms are in the subscriber edition

This transaction carries 3 stated terms, with the value, unit and basis of each and the consideration.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe